US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Akoya BioSciences Inc (AKYA)
Akoya BioSciences Inc (AKYA) ニュース

AKYA

Akoya BioSciences (AKYA)

Akoya BioSciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AKYA

1 2 3 4 5 6 7 8 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/09	21 : 00	GlobeNewswire Inc.	Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients	NASDAQ:AKYA	Akoya BioSciences Inc
2024/05/06	21 : 00	GlobeNewswire Inc.	Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts	NASDAQ:AKYA	Akoya BioSciences Inc
2024/05/02	21 : 00	GlobeNewswire Inc.	Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows	NASDAQ:AKYA	Akoya BioSciences Inc
2024/04/23	05 : 05	GlobeNewswire Inc.	Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024	NASDAQ:AKYA	Akoya BioSciences Inc
2024/04/05	21 : 00	GlobeNewswire Inc.	Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale	NASDAQ:AKYA	Akoya BioSciences Inc
2024/03/05	07 : 18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AKYA	Akoya BioSciences Inc
2024/03/05	06 : 05	GlobeNewswire Inc.	Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook	NASDAQ:AKYA	Akoya BioSciences Inc
2024/03/04	20 : 01	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:AKYA	Akoya BioSciences Inc
2024/03/02	11 : 58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKYA	Akoya BioSciences Inc
2024/03/02	11 : 58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKYA	Akoya BioSciences Inc
2024/03/02	11 : 53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKYA	Akoya BioSciences Inc
2024/03/02	11 : 53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKYA	Akoya BioSciences Inc
2024/03/02	11 : 52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKYA	Akoya BioSciences Inc
2024/03/02	11 : 52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKYA	Akoya BioSciences Inc
2024/03/02	11 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKYA	Akoya BioSciences Inc
2024/02/12	23 : 11	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:AKYA	Akoya BioSciences Inc
2024/02/09	06 : 05	GlobeNewswire Inc.	Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference	NASDAQ:AKYA	Akoya BioSciences Inc
2024/01/18	22 : 00	GlobeNewswire Inc.	Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases	NASDAQ:AKYA	Akoya BioSciences Inc
2024/01/11	06 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AKYA	Akoya BioSciences Inc
2024/01/10	22 : 00	GlobeNewswire Inc.	Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., Join Newly Created Scientific Advisory Board	NASDAQ:AKYA	Akoya BioSciences Inc
2024/01/09	05 : 57	Dow Jones News	Akoya Biosciences Shares Jump on 2024 Outlook, Thermo Fisher Deal	NASDAQ:AKYA	Akoya BioSciences Inc
2024/01/08	20 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AKYA	Akoya BioSciences Inc
2024/01/07	22 : 00	GlobeNewswire Inc.	Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook	NASDAQ:AKYA	Akoya BioSciences Inc
2024/01/07	22 : 00	GlobeNewswire Inc.	Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics Workflow	NASDAQ:AKYA	Akoya BioSciences Inc
2024/01/07	22 : 00	GlobeNewswire Inc.	Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine Platform	NASDAQ:AKYA	Akoya BioSciences Inc
2024/01/03	22 : 50	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:AKYA	Akoya BioSciences Inc
2023/12/21	09 : 16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKYA	Akoya BioSciences Inc
2023/12/20	22 : 05	GlobeNewswire Inc.	Akoya to Participate at 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:AKYA	Akoya BioSciences Inc
2023/12/20	06 : 23	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AKYA	Akoya BioSciences Inc
2023/12/15	06 : 24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKYA	Akoya BioSciences Inc

Showing the most relevant articles for your search:NASDAQ:AKYA

1 2 3 4 5 6 7 8 次へ >>

US Dollar vs Euro

Gold vs US Dollar

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約